<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04840797</url>
  </required_header>
  <id_info>
    <org_study_id>TC_ECR_HS1_2020_10819</org_study_id>
    <nct_id>NCT04840797</nct_id>
  </id_info>
  <brief_title>HeartStart HS1 Defibrillator* Event Registry</brief_title>
  <official_title>HeartStart HS1 Defibrillator* Event Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Clinical &amp; Medical Affairs Global</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Clinical &amp; Medical Affairs Global</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Prospective study on the performance and safety of the HeartStart OnSite (Model M5066A) &amp;&#xD;
      HeartStart Home (Model M5068A) Defibrillator device data.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this PMCF (Post Market Clinical Follow-up) prospective collection of&#xD;
      post-event data registry is to confirm the safety and performance as expressed in the energy&#xD;
      delivery by the HeartStart HS1 Defibrillator (HeartStart OnSite and Home models in North&#xD;
      America) in the population for the device's intended use in reference to its commercial&#xD;
      labeling, and in relationship to the type of pads attached to the device.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 25, 2021</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Mean shock energy delivered in the pediatric population</measure>
    <time_frame>Up to 15 minutes during device placement</time_frame>
    <description>Mean of shock energy delivered, when the pediatric defibrillation pads were attached to the AED as intended for infants and children under 25 kilograms / 55 pounds or 0-8 years old.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean shock energy delivered in the adult population</measure>
    <time_frame>Up to 15 minutes during device placement</time_frame>
    <description>Mean of shock energy delivered, when the adult defibrillation pads were attached to the AED as intended for in children and adults over 25 kilograms / 55 pounds or greater than 8 years old.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency and severity of unexpected adverse events</measure>
    <time_frame>Up to 15 minutes during device placement</time_frame>
    <description>Frequency and severity of unexpected adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unanticipated adverse device effects (UADE)</measure>
    <time_frame>Up to 15 minutes during device placement</time_frame>
    <description>Unanticipated adverse device effects (UADE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median operating time intervals</measure>
    <time_frame>Up to 15 minutes during device placement</time_frame>
    <description>Median operating time intervals</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Routine self-test performance/Battery Insertion self-test performance</measure>
    <time_frame>Up to 15 minutes during device placement</time_frame>
    <description>Routine self-test performance/Battery Insertion self-test performance</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1400</enrollment>
  <condition>Sudden Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>Suspected Sudden Cardiac Arrest</arm_group_label>
    <description>All subjects with suspected of a circulatory arrest of any cause.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HeartStart HS1</intervention_name>
    <description>Automated External Defibrillator</description>
    <arm_group_label>Suspected Sudden Cardiac Arrest</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Anyone who is suspected of having a sudden cardiac arrest.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have been suspected of a circulatory arrest for any cause.&#xD;
&#xD;
          -  Have had HeartStart HS1 Defibrillator with electrodes:&#xD;
&#xD;
        Adult SMART Pads Cartridge [REF: M5071A], Infant/Child SMART Pads Cartridge (REF:M5072A)&#xD;
        applied to their body and powered up with HS1 battery (Model M5070A), regardless of whether&#xD;
        a defibrillation shock was delivered&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects will be excluded if any of the following are present:&#xD;
&#xD;
          -  AED or pad use other than the HeartStart HS1 Defibrillator with above referenced&#xD;
             Philips electrode pads. Note: Use of a device other than the Philips HeartStart HS1&#xD;
             AED does not preclude enrollment if the AED or an Advanced Life Support defibrillator&#xD;
             was used after the HeartStart HS1 AED.&#xD;
&#xD;
          -  AED used for training purposes.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerrit Noordergraaf, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Philips Healthcare</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Lee</last_name>
    <phone>412-542-3462</phone>
    <email>Andrew.Lee@philips.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Barbara Fink</last_name>
    <phone>724-708-7048</phone>
    <email>barb.fink@philips.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Philips</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Lee</last_name>
      <phone>412-542-3462</phone>
      <email>andrew.lee@philips.com</email>
    </contact>
    <investigator>
      <last_name>Gerrit Nordergraaf, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 7, 2021</study_first_submitted>
  <study_first_submitted_qc>April 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AED</keyword>
  <keyword>Post -Market</keyword>
  <keyword>Cardiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

